Alaunos Therapeutics (TCRT) Amortization of Deferred Charges (2021 - 2023)
Alaunos Therapeutics (TCRT) reported Amortization of Deferred Charges of $867000.0 for Q2 2023, up 318.84% on a YoY basis from $207000.0 in Q2 2022, and up 83.69% quarter-over-quarter from $472000.0 in Q1 2023.
Alaunos Therapeutics (TCRT) Amortization of Deferred Charges (2021 - 2023) Analysis & Trends
Alaunos Therapeutics has reported Amortization of Deferred Charges for 3 years, with the latest figure at $867000.0 in Q2 2023.
- For the quarter ending Q2 2023, Amortization of Deferred Charges rose 318.84% year-over-year to $867000.0; the trailing twelve-month figure through Mar 2024 stood at $867000.0 (down 30.92% YoY), and the FY2023 full-year result was $1.3 million, up 36.49% from the prior year.
- Amortization of Deferred Charges for Q2 2023 stood at $867000.0, up from $472000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $867000.0 in Q2 2023, with the low at $148000.0 in Q3 2021.
- Historically, Amortization of Deferred Charges has averaged $337875.0 across 3 years, with a median of $232000.0 in 2021.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges surged 47.66% — and 2023, when it jumped 318.84%.
- Alaunos Therapeutics' Amortization of Deferred Charges stood at $235000.0 in 2021, then surged by 47.66% to $347000.0 in 2022, then surged by 149.86% to $867000.0 in 2023.
- The last three Amortization of Deferred Charges figures came in at $867000.0 (Q2 2023), $472000.0 (Q1 2023), and $347000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 867,000.00 |
| Jun 30, 2023 | 867,000.00 |
| Mar 31, 2023 | 472,000.00 |
| Mar 31, 2023 | 472,000.00 |
| Dec 31, 2022 | 347,000.00 |
| Dec 31, 2022 | 347,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Sep 30, 2021 | 148,000.00 |